These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25648649)

  • 1. Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trial.
    Perito ER; Mohammad S; Rosenthal P; Alonso EM; Ekong UD; Lobritto SJ; Feng S
    Am J Transplant; 2015 Mar; 15(3):779-85. PubMed ID: 25648649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review.
    Rothbaum Perito E; Lau A; Rhee S; Roberts JP; Rosenthal P
    Liver Transpl; 2012 Sep; 18(9):1009-28. PubMed ID: 22641460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Feng S; Demetris AJ; Spain KM; Kanaparthi S; Burrell BE; Ekong UD; Alonso EM; Rosenthal P; Turka LA; Ikle D; Tchao NK
    Hepatology; 2017 Feb; 65(2):647-660. PubMed ID: 27302659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.
    Shaked A; DesMarais MR; Kopetskie H; Feng S; Punch JD; Levitsky J; Reyes J; Klintmalm GB; Demetris AJ; Burrell BE; Priore A; Bridges ND; Sayre PH
    Am J Transplant; 2019 May; 19(5):1397-1409. PubMed ID: 30506630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Syndrome Components After Pediatric Liver Transplantation: Prevalence and the Impact of Obesity and Immunosuppression.
    Perito ER; Lustig RH; Rosenthal P
    Am J Transplant; 2016 Jun; 16(6):1909-16. PubMed ID: 26751054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients.
    Blöte R; Memaran N; Borchert-Mörlins B; Thurn-Valsassina D; Goldschmidt I; Beier R; Sauer M; Müller C; Sarganas G; Oh J; Büscher R; Kemper MJ; Sugianto RI; Epping J; Schmidt BMW; Melk A
    Transplantation; 2019 Nov; 103(11):2423-2433. PubMed ID: 30801541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea.
    Lee JH; Lee SK; Lee HJ; Seo JM; Joh JW; Kim SJ; Kwon CH; Choe YH
    Yonsei Med J; 2009 Dec; 50(6):784-8. PubMed ID: 20046418
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Center variation in screening for and management of metabolic syndrome in pediatric liver transplant recipients: A survey of SPLIT centers.
    Hilk K; Zerofsky M; Rhee S; Rosenthal P; Perito ER
    Pediatr Transplant; 2019 May; 23(3):e13347. PubMed ID: 30664821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
    Feng S; Ekong UD; Lobritto SJ; Demetris AJ; Roberts JP; Rosenthal P; Alonso EM; Philogene MC; Ikle D; Poole KM; Bridges ND; Turka LA; Tchao NK
    JAMA; 2012 Jan; 307(3):283-93. PubMed ID: 22253395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.
    Manzia TM; Angelico R; Ciano P; Mugweru J; Owusu K; Sforza D; Toti L; Tisone G
    World J Gastroenterol; 2014 Sep; 20(34):12217-25. PubMed ID: 25232255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
    Feng S; Bucuvalas JC; Mazariegos GV; Magee JC; Sanchez-Fueyo A; Spain KM; Lesniak A; Kanaparthi S; Perito E; Venkat VL; Burrell BE; Alonso EM; Bridges ND; Doo E; Gupta NA; Himes RW; Ikle D; Jackson AM; Lobritto SJ; Jose Lozano J; Martinez M; Ng VL; Rand EB; Sherker AH; Sundaram SS; Turmelle YP; Wood-Trageser M; Demetris AJ
    Hepatology; 2021 May; 73(5):1985-2004. PubMed ID: 32786149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
    Perito ER; Martinez M; Turmelle YP; Mason K; Spain KM; Bucuvalas JC; Feng S
    Am J Transplant; 2019 May; 19(5):1545-1551. PubMed ID: 30614623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors.
    Perito ER; Lustig RH; Rosenthal P
    J Pediatr; 2017 Mar; 182():223-231.e3. PubMed ID: 28041666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and Exercise in Pediatric Liver Transplant Recipients: Behaviors and Association With Metabolic Syndrome.
    Chambers JH; Zerofsky M; Lustig RH; Rosenthal P; Perito ER
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):81-88. PubMed ID: 30234760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death.
    Hu LS; Chai YC; Zheng J; Shi JH; Zhang C; Tian M; Lv Y; Wang B; Jia A
    World J Gastroenterol; 2018 Nov; 24(43):4920-4927. PubMed ID: 30487701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.
    Laish I; Braun M; Mor E; Sulkes J; Harif Y; Ben Ari Z
    Liver Transpl; 2011 Jan; 17(1):15-22. PubMed ID: 21254340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Atherosclerosis in Pediatric Liver Transplant Recipients: Carotid and Aorta Intima-Media Thickness and Their Predictors.
    Perito ER; Phelps A; Vase T; Feldstein VA; Lustig RH; Rosenthal P
    J Pediatr; 2018 Feb; 193():119-127.e1. PubMed ID: 29224938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.
    Penninga L; Wettergren A; Chan AW; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008852. PubMed ID: 22419339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.